Precision Chromatography & Natural Medicine CRO / CDMO

China High-Performance Liquid Chromatography (HPLC) Supplier & Analytical Solutions

Empowering global life sciences, botanical medicine, and chemical enterprises with cGMP-compliant chromatographic method development, high-throughput active ingredient screening, validation, and commercial isolation.

Primary HPLC & CRO Capabilities

Featured HPLC Analytical & Botanical Contract Services

Browse our premier analytical method establishment, potency evaluation, and clinical research packages. Backed by 14+ years of industrial delivery and accredited chromatographic instrumentation.

China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers

China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers

View Specifications
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers

ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers

View Specifications
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers

China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers

View Specifications
ODM Study and evaluation of the potency of the botanical active ingredient(s)

ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins

View Specifications
OEM In Vitro Test /Research Service Manufacturers, Suppliers

OEM In Vitro Test /Research Service Manufacturers, Suppliers

View Specifications
OEM Animal study Supplier, Suppliers

OEM Animal study Supplier, Suppliers

View Specifications
HPLC and HPTLC analytical method establishment for active ingredients

HPLC & HPTLC Analytical Method Establishment & Validation

View Specifications
Screening of botanical active ingredients in plants

Botanical Active Ingredients Screening & Preparative Isolation

View Specifications
Industry Strategic White Paper

The Strategic Rise of Chinese HPLC Suppliers & Analytical CDMOs

How China’s analytical instrumentation hubs and cGMP contract research organizations transformed from low-tier testing labs into global leaders of chromatographic method validation, high-purity phytochemical separation, and regulatory compliance.

Chromatographic Infrastructure Scale

China has built one of the densest footprints of high-performance liquid chromatography systems globally. Leading facilities house hundreds of UHPLC, HPLC-MS/MS, and preparative chromatography trains under strict temperature- and humidity-controlled cleanrooms, allowing multinational sponsors to compress analytical turnaround times by up to 65% compared to Western contract testing bureaus.

ICH Q2(R2) & ALCOA+ Data Integrity

Modern Chinese chromatographic providers have completely overhauled their quality management systems. Operating under US FDA 21 CFR Part 11, EU Annex 11, and Chinese Pharmacopoeia (ChP) regulations, every injection is cataloged with full electronic audit trails, automated system suitability testing (SST), and non-rewritable raw data archives, providing unimpeachable regulatory acceptance.

Natural Product & Complex Matrix Mastery

Isolating and quantifying active ingredients from complex natural matrices (e.g., saponins, flavonoids, alkaloids, polysaccharides) requires nuanced mobile phase gradient tailoring and stationary phase selection. With deep roots in botanical medicine research, Chinese suppliers excel in resolving overlapping peaks, isomer separations, and trace impurity quantification where standard methods fail.

Procurement Intelligence

Global Enterprise HPLC Procurement Requirements Matrix

Strategic procurement officers, VP of Quality, and Principal Analytical Investigators require specific technical configurations depending on target analyte classification, column selectivity, and detection chemistry.

Analytical Application Detection Technology Stationary Phase Chemistry Regulatory Benchmark Key Performance Metrics
Botanical Active Fingerprinting DAD / PDA & High-Res Q-TOF MS Core-Shell C18 / RP-Amide (1.7–2.7 µm) ChP Vol I / USP <203> / EP 2.8.25 RSD ≤ 1.0%, Peak Capacity > 120, Zero Co-elution
API Impurity & Degradation Profiling UV-Vis / CAD / Charged Aerosol C8, Phenyl-Hexyl, Mixed-Mode ICH Q3A/B(R2), ICH Q2(R2) LOQ ≤ 0.05%, Linearity r ≥ 0.999, Mass Balance ≥ 98.5%
Polysaccharides & Large Macromolecules RID (Refractive Index) / ELSD / MALS Size-Exclusion (SEC / GPC), Diol USP <621>, EP 2.2.30 Molecular Weight Range 1kDa–1000kDa, Low Drift
Enantiomeric / Chiral Separations Polarimetry / DAD / Triple Quad MS Polysaccharide-Derived Chiral Columns FDA Guidance for Stereoisomeric Drugs Enantiomeric Excess (ee%) > 99.5%, Baseline Separation Rs > 2.0
Preparative Bulk Active Extraction Preparative Flow Cell UV / MS-Triggered Polymeric Reversed Phase (10–30 µm) cGMP API Supply Guidelines Purity ≥ 98.0%, Yield ≥ 88%, Solvent Recovery > 92%
Authority & Operational Scale

MedGence (Yineng Pharma) Laboratory Infrastructure

Headquartered in Changsha, Hunan, MedGence provides complete end-to-end integration: from raw botanical screening and HPLC standard creation to pilot extraction and full clinical trials.

14+
Years of R&D Experience
300+
Senior Research Scientists
100+
Pharma & Hospital Partners
83
Classic TCM Formulas Modernized
22
Innovative Natural Drugs
56
Hospital Preparation Approvals
~400
Single-Herb Standards Established
100%
Proprietary IP Protection
Cross-Sector Solutions

Macro-Industry Chromatography & CRO Solutions

How our high-precision liquid chromatography capabilities integrate into global dietary supplement brands, clinical development programs, and finished OEM/CDMO manufacturing.

Nutraceutical & Botanical Standardisation

Commercial natural extracts often suffer from severe batch-to-batch variation due to wild harvest differences. We utilize multi-wavelength HPLC fingerprinting to evaluate potency variations across harvest seasons, geographical origins, and plant anatomical parts. This guarantees stable target marker concentration in finished dietary supplements, softgels, and powders.

Phytochemical NDA Drug Discovery

Moving botanical candidates from bench to investigational new drug (IND) applications requires rigorous purity guarantees. We deliver full analytical packages: identifying lead compounds through preparative HPLC fraction collection, establishing structure through 2D-NMR/LC-MS, and executing in vitro receptor binding assays and animal pharmacokinetic studies.

Clean-Label Cosmetics & Actives

For global personal care formulators, HPLC verification ensures zero adulteration, limits residual solvents to trace levels below safety thresholds, and validates the stability of active molecules (such as polyphenols, ginsenosides, and bakuchiol) under varying emulsification and storage conditions.

Integrated CDMO Pilot-to-Commercial Scale

Unlike pure analytical testing houses, our technical team directly manages industrial pilot plants and manufacturing facilities. Validated chromatographic extraction methods transfer seamlessly into commercial production of concentrated liquids, crystalline powders, pastes, and finished solid or liquid dosage forms.

Analytical Evolution

Technology Roadmap: High-Performance Chromatography (2025–2030)

How artificial intelligence, microfluidic column technology, and green mobile phase chemistry are reshaping the speed, precision, and sustainability of Chinese HPLC manufacturing and testing.

Phase 1: 2025

AI Peak Deconvolution & In Silico Method Modeling

Implementation of machine-learning retention time modeling. Algorithms predict chromatographic retention behavior across varying solvent gradients, pH ranges, and column stationary phases, compressing method development from weeks to under 48 hours.

Phase 2: 2026–2027

Green SFC & Supercritical CO2 Integration

Transitioning high-volume preparative isolation from conventional organic solvent systems to Supercritical Fluid Chromatography (SFC). Reduces toxic solvent usage (acetonitrile/methanol) by up to 85% while drastically lowering carbon emissions during active ingredient purification.

Phase 3: 2028–2029

Microfluidic Chip-Based PAT Chromatography

Embedding lab-on-a-chip miniaturized UHPLC channels directly into commercial extraction bioreactors. Enables real-time Process Analytical Technology (PAT) monitoring, instantly tuning industrial extraction temperatures and pressures as active fractions reach peak purity.

Phase 4: 2030 Horizon

Autonomous Closed-Loop Quality Control

Fully automated robotic injection, mobile phase replenishment, self-diagnostic system suitability troubleshooting, and direct blockchain-anchored certificate of analysis (CoA) generation with zero human manual intervention.

Enterprise Trust

Trusted by 100+ Leading Pharmaceutical Groups & Hospitals

Our verified chromatographic data packages, TCM modernization protocols, and formulation dossiers are trusted by China’s preeminent public hospitals and listed pharmaceutical corporations.

Beijing TongrentangBeijing Tongrentang Group
CR SanjiuChina Resources Sanjiu
Sunflower PharmaSunflower Pharmaceutical
Livzon PharmaLivzon Pharmaceutical Group
Dihon PharmaDihon Pharmaceutical
Golden ThroatGolden Throat Group
Yangtzi River PharmaYangtzi River Pharma
Beihai GofarBeihai Gofar Chuanshan
HumanwellHumanwell Healthcare
SCIMYTHSCIMYTH Pharma Group
HanfangShandong Hanfang Pharma
LuoxinLuoxin Pharmaceutical
ZhongshengGuangdong Zhongsheng Pharma
Brilliance AbundanceHunan Brilliance & Abundance
ApeloaApeloa Pharmaceutical
Heng ChangHunan Heng Chang Pharma
Baotou TCMBaotou TCM Co., Ltd.
Kamp MedicineKamp Medicine Co., Ltd.
Santo PharmaGuangxi Santo Pharmaceutical
KangshouHunan Kangshou Pharma
JuwangJiangxi Juwang Pharma
TcmagesBeijing Tcmages Pharma
RuiheGuizhou Ruihe Pharmaceutical
CR JinchanAnhui CR Jinchan Pharma
KangmeiKangmei Pharmaceutical
TianjicaotangHunan Tianjicaotang Pharma
KingstoneJiangxi Kingstone Unite
Shuguang HospitalShuguang Hospital (Shanghai TCM)
Hunan TCM HospitalHunan Directly Affiliated TCM Hospital
First HospitalFirst Hospital of Hunan Univ. of CM
Second XiangyaSecond Xiangya Hospital (CSU)
Second HospitalSecond Hospital of Hunan Univ. of CM
Zhuzhou OrthopedicsZhuzhou City TCM Orthopedics
Complete Project Sourcing

Explore Our Full Chromatographic & Preclinical Catalog

Select any service to request method validation protocols, LOD/LOQ calibration curves, or initiate custom extraction pilot trials with our technical scientific board.

China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers

China Establishment of analysis methods of active ingredient(s) Supplier, Suppliers

Request Protocol
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers

ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers

Request Protocol
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers

China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers

Request Protocol
ODM Study and evaluation of the potency of the botanical active ingredient(s)

ODM Study and evaluation of the potency of the botanical active ingredient(s) from different seasons and different origins

Request Protocol
OEM In Vitro Test /Research Service Manufacturers, Suppliers

OEM In Vitro Test /Research Service Manufacturers, Suppliers

Request Protocol
OEM Animal study Supplier, Suppliers

OEM Animal study Supplier, Suppliers

Request Protocol
HPLC and HPTLC analytical method establishment for active ingredients

HPLC & HPTLC Analytical Method Establishment & Validation

Request Protocol
Screening of botanical active ingredients in plants

Botanical Active Ingredients Screening & Preparative Isolation

Request Protocol
Compliance & Global Assurance

Regulatory Compliance, Local Support & IP Protection

Safeguarding client assets through internationally accepted compliance frameworks, dedicated bilingual project managers, and strictly enforced non-disclosure confidentiality agreements.

Total IP Protection & NDA Isolation

Under our entrusted contract research structure, proprietary formulations, molecular target maps, and chromatographic parameters are strictly isolated on air-gapped laboratory servers. Project data is strictly confidential and never licensed or disclosed to third parties.

Regulatory Dossier Compilation

We deliver complete Chemistry, Manufacturing, and Controls (CMC) packages formatted for US FDA (NDI/GRAS, IND), EFSA Novel Food, and NMPA filings. Includes method validation protocols covering Specificity, Linearity, Range, Accuracy, Precision, Repeatability, and Intermediate Precision per ICH Q2(R2).

Dedicated Bilingual Tech PM Support

Every overseas enterprise is assigned an analytical chemist project manager fluent in English. Bi-weekly video conferences, real-time chromatogram sharing, and transparent milestone tracking remove cross-border communication barriers and ensure on-time delivery.

Direct Buyer Answers

Frequently Asked Questions: Global HPLC & CRO Sourcing

Essential technical and operational answers for analytical directors, sourcing managers, and regulatory leaders evaluating China HPLC analytical suppliers.

What specific HPLC detection modalities does MedGence operate?
Our central analytical laboratory houses multi-vendor systems (Agilent 1260/1290 Infinity II, Waters ACQUITY UPLC, Shimadzu Prominence) equipped with Photodiode Array (PDA/DAD), Refractive Index Detectors (RID), Fluorescence Detectors (FLD), Evaporative Light Scattering Detectors (ELSD), Charged Aerosol Detectors (CAD), and hyphenated Triple-Quadrupole and Q-TOF Mass Spectrometers (LC-MS/MS).
How do you validate an analytical method for botanical active ingredients?
We follow ICH Q2(R2) and USP <1225> guidelines. Validation encompasses System Suitability Testing (theoretical plates, tailing factor, resolution), Specificity/Selectivity (resolving target markers from matrix interferences), Linearity and Range (r ≥ 0.999), Accuracy (spike recovery across 50%, 100%, and 150% concentrations), Precision (intra-day and intermediate inter-day RSD ≤ 2.0%), and Robustness against flow rate, column temperature, and mobile phase organic modifier shifts.
Can you transition analytical HPLC methods into commercial-scale preparative isolation?
Yes. Our process chemistry division utilizes geometric scale-up principles to transfer analytical HPLC methods directly into pilot DAC (Dynamic Axial Compression) preparative chromatography columns (ID 50mm to 600mm). This enables high-purity isolation of target natural compounds from gram quantities up to metric tons of active pharmaceutical ingredients (APIs).
How does MedGence handle chromatographic data integrity and audit trails?
All analytical chromatography software packages (Waters Empower, Agilent OpenLab CDS) are maintained under strict US FDA 21 CFR Part 11 and cGMP data integrity protocols. System access uses role-based security, audit trails record every injection and recalculation, and raw data is stored in unalterable optical/cloud storage archives with complete disaster recovery.
What dosage forms and bulk active ingredient physical states can you deliver?
Through our CDMO facilities, active botanical ingredients can be formulated and delivered as purified standardized dry powders, vacuum-concentrated liquids, lipophilic pastes, or supercritical volatile essential oils. Finished dosage formats include hard gelatin and vegetarian HPMC capsules, softgels, micro-tablets, enteric-coated granules, and oral solution vials.
What typical turnaround times can global buyers expect for custom method development?
Standard feasibility screening and preliminary method development typically take 10 to 14 business days. Full ICH Q2(R2) validation dossiers with complete stress testing (acid, base, peroxide, thermal, and photolytic degradation) require approximately 3 to 4 weeks, with expedited 14-day turnaround options available for time-sensitive regulatory filings.
Do you support preclinical toxicology and clinical Phase I–IV evaluation?
Yes. In addition to HPLC analytical development, our integrated CRO division conducts in vitro cellular bioassays, in vivo pharmacokinetic/pharmacodynamic (PK/PD) studies, acute LD50 and chronic toxicity screenings, as well as formal Phase I to Phase IV human clinical trials designed to satisfy international new drug applications (NDAs).